# Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia

> **NCT01352234** · PHASE4 · COMPLETED · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 104 (actual)

## Conditions studied

- Pre-Eclampsia
- Fetal Growth Retardation
- Premature Birth
- Placental Insufficiency

## Interventions

- **DRUG:** Acetylsalicylic Acid 160 mg
- **DRUG:** Acetylsalicylic Acid 80 mg

## Key facts

- **NCT ID:** NCT01352234
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-12
- **Final completion:** 2015-03
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352234, "Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01352234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
